The New Technology Addon Payment (NTAP) Program What Life Sciences Companies Should Know About

2025 New Technology Add On Payment. New Technologies In 2025 Eugine Opalina The cost criterion evaluates whether the cost of the new technology or service exceeds the predefined 75% cost-to-charge thresholds established with the release of the most recent annual IPPS final rule. Two new substances that received NTAP approval are Casgevy™ and Lyfgenia™

The Future of Digital Payments OSG
The Future of Digital Payments OSG from osgconnect.com

cms finalizes changes to new technology add-on payment policies for fy 2025 and fy 2026 and approves new technologies for add-on payments The new technology add-on payment (NTAP) program allows for an additional payment for medical services or technologies that are found to be: (1) new; (2) disproportionately costly to the existing MS-DRG; and (3) a substantial clinical improvement. For FY 2025 Medicare will make an add-on payment equal to the.

The Future of Digital Payments OSG

Reporting of newly approved NTAP technologies, devices and substances for FY 2025 went into effect on October 1 Edwards Lifesciences estimates there will be 800 cases when this new technology will be used in FY 2025 For FY 2025, 24 technologies continue to be eligible for new technology add-on payments, and 15 new applications are eligible for new technology add-on payments

The Future of Digital Payments OSG. This year's final rule includes a 2.9 percent increase in overall IPPS payments, an increase in the NTAP percentage from 65 percent to 75 percent for certain gene therapies approved for new technology add-on payments when indicated and used specifically for the treatment of sickle cell disease, and separate IPPS payment for establishing and maintaining access to essential medicines. For more information on FY 2025 new technology add-on payments, specifically regarding the technologies either continuing to receive payments or starting to receive payments, see MAC.

How a New Technology AddOn Payment (NTAP) Works Avalere Health. cms finalizes changes to new technology add-on payment policies for fy 2025 and fy 2026 and approves new technologies for add-on payments The new technology add-on payment (NTAP) program allows for an additional payment for medical services or technologies that are found to be: (1) new; (2) disproportionately costly to the existing MS-DRG; and (3) a substantial clinical improvement. Effective October 1, 2024, the EVOQUE™ system has been approved for the new technology add-on payment